Articles | Volume 11, issue 1
https://doi.org/10.5194/jbji-11-21-2026
https://doi.org/10.5194/jbji-11-21-2026
Original full-length article
 | 
12 Jan 2026
Original full-length article |  | 12 Jan 2026

Fluoroquinolones vs. tetracycline agents combined with rifampicin for periprosthetic joint infections: a comparative study

Benoit Gachet, Olivier Robineau, Maxime Degrendel, Jules Bauer, Bertrand Cappeliez, Emmanuelle Bontemps, Ava Diarra, Pierre Patoz, Eric Beltrand, Eric Senneville, and Barthelemy Lafon-Desmurs

Viewed

Total article views: 786 (including HTML, PDF, and XML)
HTML PDF XML Total BibTeX EndNote
559 166 61 786 29 29
  • HTML: 559
  • PDF: 166
  • XML: 61
  • Total: 786
  • BibTeX: 29
  • EndNote: 29
Views and downloads (calculated since 12 Jan 2026)
Cumulative views and downloads (calculated since 12 Jan 2026)

Viewed (geographical distribution)

Total article views: 778 (including HTML, PDF, and XML) Thereof 778 with geography defined and 0 with unknown origin.
Country # Views %
  • 1
1
 
 
 
 
Latest update: 16 Apr 2026
Download
Short summary
Infections represent a serious complication following the implantation of osteoarticular devices. Rifampicin in combination with fluoroquinolone is the most prescribed antibiotic regimen. Nevertheless, fluoroquinolones are associated with significant adverse effects. We sought to evaluate whether oral tetracyclines could serve as an alternative therapeutic option. Our findings suggest that tetracyclines may constitute a suitable alternative in cases where fluoroquinolones are not usable.
Share